Larry Lai Wei

1.5k total citations
10 papers, 1.2k citations indexed

About

Larry Lai Wei is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Larry Lai Wei has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Larry Lai Wei's work include Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (4 papers) and Immune cells in cancer (3 papers). Larry Lai Wei is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (4 papers) and Immune cells in cancer (3 papers). Larry Lai Wei collaborates with scholars based in Hong Kong, United States and China. Larry Lai Wei's co-authors include Irene Oi‐Lin Ng, Chun‐Ming Wong, Carmen Chak‐Lui Wong, David Kung‐Chun Chiu, Robin Kit‐Ho Lai, Mingjing Xu, Aki Pui‐Wah Tse, Felice Ho‐Ching Tsang, Regina Cheuk‐Lam Lo and Derek Lee and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Gastroenterology.

In The Last Decade

Larry Lai Wei

10 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry Lai Wei Hong Kong 8 570 434 430 395 155 10 1.2k
Aki Pui‐Wah Tse Hong Kong 14 764 1.3× 386 0.9× 600 1.4× 358 0.9× 271 1.7× 17 1.4k
Ling–Qun Kong China 19 586 1.0× 489 1.1× 411 1.0× 448 1.1× 139 0.9× 23 1.3k
Rakesh R. Ramjiawan United States 6 434 0.8× 449 1.0× 282 0.7× 688 1.7× 222 1.4× 7 1.3k
Yan‐Miao Huo China 21 559 1.0× 276 0.6× 435 1.0× 534 1.4× 184 1.2× 54 1.2k
Laura G.M. Daenen Netherlands 14 612 1.1× 216 0.5× 424 1.0× 679 1.7× 192 1.2× 30 1.3k
Rugui Li China 5 522 0.9× 362 0.8× 317 0.7× 437 1.1× 340 2.2× 8 1.1k
Ti Wen China 24 638 1.1× 391 0.9× 319 0.7× 521 1.3× 146 0.9× 48 1.2k
Zhihua Li China 23 919 1.6× 254 0.6× 808 1.9× 738 1.9× 179 1.2× 50 1.6k

Countries citing papers authored by Larry Lai Wei

Since Specialization
Citations

This map shows the geographic impact of Larry Lai Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Lai Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Lai Wei more than expected).

Fields of papers citing papers by Larry Lai Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Lai Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Lai Wei. The network helps show where Larry Lai Wei may publish in the future.

Co-authorship network of co-authors of Larry Lai Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Lai Wei. A scholar is included among the top collaborators of Larry Lai Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Lai Wei. Larry Lai Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chiu, David Kung‐Chun, Vincent Wai‐Hin Yuen, Jacinth Wing‐Sum Cheu, et al.. (2020). Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice. Gastroenterology. 159(2). 609–623. 129 indexed citations
2.
Chiu, David Kung‐Chun, Aki Pui‐Wah Tse, Mingjing Xu, et al.. (2017). Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. Nature Communications. 8(1). 517–517. 342 indexed citations
3.
Lee, Derek, Mingjing Xu, David Kung‐Chun Chiu, et al.. (2017). Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. Journal of Clinical Investigation. 127(5). 1856–1872. 110 indexed citations
4.
5.
Lai, Robin Kit‐Ho, Mingjing Xu, David Kung‐Chun Chiu, et al.. (2016). NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma. Clinical Cancer Research. 22(12). 3105–3117. 69 indexed citations
6.
Ma, Wei, Karen Man‐Fong Sze, Lo‐Kong Chan, et al.. (2016). RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma. Oncotarget. 7(27). 41445–41459. 35 indexed citations
7.
Chiu, David Kung‐Chun, Mingjing Xu, Robin Kit‐Ho Lai, et al.. (2016). Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26. Hepatology. 64(3). 797–813. 199 indexed citations
8.
Wong, Carmen Chak‐Lui, Sandy Leung–Kuen Au, Aki Pui‐Wah Tse, et al.. (2014). Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis. PLoS ONE. 9(12). e115036–e115036. 66 indexed citations
9.
Wong, Carmen Chak‐Lui, Yanping Huang, Yanting Zhu, et al.. (2014). Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 60(5). 1645–1658. 205 indexed citations
10.
Ng, Irene Oi‐Lin, et al.. (2012). Abstract 1059: SUV39H1 promotes HCC tumorigenesis and is targeted by tumor suppressive miRNA-125b. Cancer Research. 72(8_Supplement). 1059–1059. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aki Pui‐Wah Tse Breakdown of academic impact, for papers by Ling–Qun Kong Breakdown of academic impact, for papers by Rakesh R. Ramjiawan Breakdown of academic impact, for papers by Yan‐Miao Huo Breakdown of academic impact, for papers by Laura G.M. Daenen Breakdown of academic impact, for papers by Rugui Li Breakdown of academic impact, for papers by Ti Wen Breakdown of academic impact, for papers by Zhihua Li
Rankless by CCL
2026